| # | Drug | Count |
|---|---|---|
| 0 | EVOLOCUMAB | 24856 |
| 1 | SOMATROPIN | 19220 |
| 2 | ALBUTEROL SULFATE | 10233 |
| 3 | ERENUMAB-AOOE | 6743 |
| 4 | ETANERCEPT | 3110 |
| 5 | ALBUTEROL | 2372 |
| 6 | PEGFILGRASTIM | 2121 |
| 7 | SECUKINUMAB | 1001 |
| 8 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 672 |
| 9 | GALCANEZUMAB-GNLM | 579 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOMATROPIN | 19220 | 0.2567 |
| 1 | OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE | 520 | 0.2555 |
| 2 | TESTOSTERONE GEL, 1% | 65 | 0.2549 |
| 3 | PEGFILGRASTIM | 2121 | 0.1771 |
| 4 | ADALIMUMAB-ATTO | 247 | 0.1534 |
| 5 | EVOLOCUMAB | 24856 | 0.1506 |
| 6 | LEVALBUTEROL TARTRATE | 556 | 0.1489 |
| 7 | ERENUMAB-AOOE | 6743 | 0.1213 |
| 8 | USTEKINUMAB-STBA | 34 | 0.0916 |
| 9 | ALBUTEROL SULFATE AND BUDESONIDE | 88 | 0.0550 |
| # | Drug class | Count |
|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 25089 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 3789 |
| 2 | Leukocyte Growth Factor [EPC] | 2185 |
| 3 | Corticosteroid [EPC] | 1485 |
| 4 | Interleukin-17A Antagonist [EPC] | 1047 |
| 5 | Recombinant Human Growth Hormone [EPC] | 848 |
| 6 | GLP-1 Receptor Agonist [EPC] | 680 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 663 |
| 8 | Insulin Analog [EPC] | 648 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 424 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 25089 | 0.9743 |
| 1 | Recombinant Human Growth Hormone [EPC] | 848 | 0.0386 |
| 2 | Interleukin-5 Antagonist [EPC] | 24 | 0.0349 |
| 3 | Interleukin-17A Antagonist [EPC] | 1047 | 0.0281 |
| 4 | Leukocyte Growth Factor [EPC] | 2185 | 0.0153 |
| 5 | Thymic Stromal Lymphopoietin Blocker [EPC] | 78 | 0.0113 |
| 6 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 70 | 0.0100 |
| 7 | Provitamin D2 Compound [EPC] | 296 | 0.0099 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 19 | 0.0092 |
| 9 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 146 | 0.0070 |